The correlation between KRAS and TP53 gene mutations and early growth of pulmonary nodules

被引:0
|
作者
Zhao, Bin [1 ,2 ]
Li, Bin [3 ]
Guo, Haoxin [2 ]
Zhao, Qingtao [1 ]
Zhang, Xiaopeng [1 ]
Zhao, Huanfen [1 ]
Xue, Wenfei [1 ]
Li, Wei [1 ]
Duan, Guochen [4 ]
Xu, Shun [5 ]
机构
[1] Hebei Gen Hosp, Dept Thorac Surg, Shijiazhuang 050057, Peoples R China
[2] Hebei Med Univ, Grad Sch, Shijiazhuang 050011, Peoples R China
[3] Hebei Biohigh Technol Dev CO LTD, Shijiazhuang 050011, Peoples R China
[4] Childrens Hosp Hebei Prov, Dept Thorac Surg, Shijiazhuang 050000, Peoples R China
[5] China Med Univ, Dept Thorac Surg, Hosp 1, Shenyang 110000, Peoples R China
关键词
KRAS; TP53; Early pulmonary nodules; Tumor growth; LUNG-CANCER; CELL-SURVIVAL; AUTOPHAGY; PROLIFERATION; P53;
D O I
10.1186/s13019-024-02927-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
PurposeThe purpose of this study is to investigate whether gene mutations can lead to the growth of malignant pulmonary nodules. MethodsRetrospective analysis was conducted on patients with pulmonary nodules at Hebei Provincial People's Hospital, collecting basic clinical information such as gender, age, BMI, and hematological indicators. According to the inclusion and exclusion criteria, 85 patients with malignant pulmonary nodules were selected for screening, and gene mutation testing was performed on all patient tissues to explore the relationship between gene mutations and the growth of malignant pulmonary nodules. ResultsThere is a correlation between KRAS and TP53 gene mutations and the growth of pulmonary nodules (P < 0.05), while there is a correlation between KRAS and TP53 gene mutations and the growth of pulmonary nodules in the subgroup of invasive malignant pulmonary nodules (P < 0.05). ConclusionMutations in the TP53 gene can lead to the growth of malignant pulmonary nodules and are correlated with the degree of invasion of malignant pulmonary nodules.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Germline mutations in the TP53 gene
    Eeles, RA
    [J]. CANCER SURVEYS, 1995, 25 : 101 - 124
  • [2] TP53 gene mutations in canine osteosarcoma
    Kirpensteijn, Jolle
    Kik, Marja
    Teske, Erik
    Rutteman, Gerard R.
    [J]. VETERINARY SURGERY, 2008, 37 (05) : 454 - 460
  • [3] Three germline mutations in the TP53 gene
    Cornelis, RS
    vanVliet, M
    vandeVijver, MJ
    Vasen, HFA
    Voute, PA
    Top, B
    Khan, PM
    Devilee, P
    Cornelisse, CJ
    [J]. HUMAN MUTATION, 1997, 9 (02) : 157 - 163
  • [4] KRAS, BRAF and TP53 mutations in Romanian colorectal cancer patients
    Murarasu, Daniela
    Puiu, Liliana
    Mihalcea, Corina
    Cinca, Sabin
    Simion, Laurentiu
    [J]. JOURNAL OF BIOTECHNOLOGY, 2016, 231 : S92 - S92
  • [5] Germline mutations of TP53 gene in breast cancer
    Damineni, Surekha
    Rao, Vadlamudi Raghavendra
    Kumar, Satish
    Ravuri, Rajasekar Reddy
    Kagitha, Sailaja
    Dunna, Nageswara Rao
    Digumarthi, Raghunadharao
    Satti, Vishnupriya
    [J]. TUMOR BIOLOGY, 2014, 35 (09) : 9219 - 9227
  • [6] TP53 GENE MUTATIONS IN PROSTATE CANCER PROGRESSION
    Ecke, Th. H.
    Schlechte, H. H.
    Schiemenz, K.
    Sachs, M. D.
    Lenk, S. V.
    Rudolph, B. D.
    Loening, S. A.
    [J]. ANTICANCER RESEARCH, 2008, 28 (6B) : 4055 - 4056
  • [7] Profile of TP53 gene mutations in sinonasal cancer
    Holmila, Reetta
    Bornholdt, Jette
    Suitiala, Tuula
    Cyr, Diane
    Dictor, Michael
    Steiniche, Torben
    Wolff, Henrik
    Wallin, Hakan
    Luce, Daniele
    Husgafvel-Pursiainen, Kirsti
    [J]. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2010, 686 (1-2) : 9 - 14
  • [8] Role in tumorigenesis of silent mutations in the TP53 gene
    Strauss, BS
    [J]. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2000, 457 (1-2) : 93 - 104
  • [9] TP53 Gene Mutations in Prostate Cancer Progression
    Ecke, Thorsten H.
    Schlechte, Horst H.
    Schiemenz, Katrin
    Sachs, Markus D.
    Lenk, Severin V.
    Rudolph, Birgit D.
    Loening, Stefan A.
    [J]. ANTICANCER RESEARCH, 2010, 30 (05) : 1579 - 1586
  • [10] LSC-2017-KRAS & TP53 mutations cause malignant mesothelioma
    Krontira, Anthi
    Marazioti, Antonia
    Vreka, Malamati
    Iliopoulou, Marianthi
    Lilis, Ioannis
    Giotopoulou, Georgia
    Spella, Magda
    Petrou, Helen
    Stathopoulos, Georgios
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2017, 50